User Login

 

 

New User?
Trouble signing in?

Our guiding principal is that money raised local, stays local. Each of our charity swims awards their donations to a research or community hospital beneficiary. Our beneficiaries recommend early stage projects and patient programs that have the most potential. Our grants aren't focused on a specific type of cancer. In many cases, our early stage grant allows researchers to test ideas and gather data so they are in a better position to apply for additional funding from the National Institute of Health (NIH), other foundations, and industry. Our beneficiaries have reported that for every grant dollar they receive from SAA, they are able to secure $3 in new funding they might not otherwise have received.

In over three decades, Swim Across America has granted $100 million dollars that have led to breakthroughs in immunotherapy, gene therapy, personalized medicine, and patient programs. It is important donors know that our grant agreement requires 100% of SAA grants be applied to approved projects and not other things such as overhead and buildings.

There are 11 named Swim Across America research labs demonstrating the commitment and partnership of the beneficiary and Swim Across America.

 

  • SAA ACGT Lead Image

    SAA - FAIRFIELD COUNTY
    Alliance for Cancer Gene Therapy
    FOCUS: Cancer gene and cell therapy, including immunotherapy
    ACTIVE GRANT FUNDING: $340,000
    IMPACT REPORT

  • SAA ACGT Lead Image

    SAA - FLORIDA KEYS
    Miami Cancer Institute
    FOCUS: Cancer research and clinical trials.
    ACTIVE GRANT FUNDING: $100,000

  • SAA Nantucket Lead Image

    SAA - HOUSTON,
    SAA - NASSAU/SUFFOLK
    MD Anderson Cancer Center
    FOCUS:  Cancer research and clinical trials in the departments of Pediatric Oncology and Neuro-Oncology.
    ACTIVE GRANT FUNDING: $295,000

  • SAA Cancer Support Group Lead Image

    SAA - LONG ISLAND SOUND,
    SAA - NASSAU-SUFFOLK
    Swim Across America Lab
    at Memorial Sloan Kettering Cancer Center
    FOCUS: Funding immunotherapy clinical trials that have played a major role in developing four FDA approved immunotherapy medicines ipilimumab (YERVOY), nivolumab (OPDIVO), pembrolizumab (KEYTRUDA) and atezolizumab (TECENTRIQ).
    ACTIVE GRANT FUNDING: $500,000
    MEMORIAL SLOAN KETTERING TESTIMONIAL

  • SAA Cancer Support Group Lead Image

    SAA - LONG ISLAND SOUND,
    SAA - NASSAU-SUFFOLK
    Swim Across America Lab
    at Weill Cornell Medicine Meyer Cancer Center
    FOCUS: Funding immunotherapy research and clinical trials.
    ACTIVE GRANT FUNDING: $295,000

  • SAA Cancer Support Group Lead Image

    SAA - LONG ISLAND SOUND
    Columbia University Medical Center
    FOCUS: Pediatric oncology research; grant funding for pediatric patients who have tumor relapse.
    ACTIVE GRANT FUNDING: $185,000